Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study
<p>Abstract</p> <p>Background</p> <p>Dexmedetomidine, an alpha<sub>2</sub>-adrenoceptor agonist, has been evaluated as an adjunct to anesthesia and for the delivery of sedation and perioperative hemodynamic stability. It provokes dose-dependent and centrally...
Main Authors: | Scheinin Harry, Salmenperä Markku, Jalonen Jouko, Hynynen Markku, Leino Kari, Aantaa Riku |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | BMC Anesthesiology |
Online Access: | http://www.biomedcentral.com/1471-2253/11/9 |
Similar Items
-
The Effect of Dexmedetomidine on the Incidence of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery
by: Omid Azimaraghi, et al.
Published: (2018-01-01) -
Highly variable pharmacokinetics of dexmedetomidine during intensive care: a case report
by: Scheinin Mika, et al.
Published: (2010-02-01) -
Role of dexmedetomidine infusion after coronary artery bypass grafting
by: Tamer Hamouda, et al.
Published: (2020-01-01) -
Coronary Artery Bypass Surgery In a Case of Terminal Renal Failure.
by: Ashok Kumar, et al.
Published: (2002-01-01) -
Epicardial Transplantation of Autologous Cardiac Micrografts During Coronary Artery Bypass Surgery
by: Annu Nummi, et al.
Published: (2021-09-01)